Elevance Health Inc.
Elevance Health Inc. (ELV) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · ELV · as of Jun 8, 2026
Activity summary
Buy transactions
5
P-Purchase only
Sell transactions
3
12 Months
Buy/Sell ratio
1.67
Buy/Sell (by trades)
Overall sentiment
Elevance Health Inc. insiders have been net buyers of shares over the past 12 Months, which may signal confidence in the company's outlook.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
ELV insider buying and selling by quarter
ELV insider selling · ELV insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · ELV ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
ELV executive sell shares · ELV board member insider trading · ELV insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| May 19, 2026 | Penczek Ronald W CAO & Controller | Option | 877 | $273K | Form 4 |
| May 19, 2026 | Penczek Ronald W CAO & Controller | Option | 654 | $177K | Form 4 |
| May 19, 2026 | Penczek Ronald W CAO & Controller | Sale | 1,531 | $617K | Form 4 |
| May 13, 2026 | STRABLE-SOETHOUT DEANNA D Director | Award | 563 | — | Form 4 |
| May 13, 2026 | SCHULMAN AMY W Director | Award | 563 | — | Form 4 |
| May 13, 2026 | Schneider Ryan M. Director | Award | 563 | — | Form 4 |
| May 13, 2026 | PERU RAMIRO G Director | Award | 563 | — | Form 4 |
| May 13, 2026 | Neri Antonio F Director | Award | 563 | — | Form 4 |
| May 13, 2026 | Jallal Bahija Director | Award | 563 | — | Form 4 |
| May 13, 2026 | HAY LEWIS III Director | Award | 563 | — | Form 4 |
| May 13, 2026 | Dixon Robert L JR Director | Award | 563 | — | Form 4 |
| May 13, 2026 | DeVore Susan D. Director | Award | 563 | — | Form 4 |
| May 13, 2026 | COLLIS STEVEN H Director | Award | 563 | — | Form 4 |
| Mar 12, 2026 | SCHULMAN AMY W Director | Sale | 26 | $7K | Form 4 |
| Mar 6, 2026 | Kendrick Charles Morgan JR EVP & President, Commercial | Sale | 3,196 | $911K | Form 4 |
| Mar 5, 2026 | COLLIS STEVEN H Director | Purchase | 3,000 | $870K | Form 4 |
| Mar 2, 2026 | Penczek Ronald W CAO & Controller | Award | 266 | — | Form 4 |
| Mar 3, 2026 | Penczek Ronald W CAO & Controller | Other | 37 | $11K | Form 4 |
| Mar 2, 2026 | Penczek Ronald W CAO & Controller | Award | 1,701 | — | Form 4 |
| Mar 2, 2026 | Penczek Ronald W CAO & Controller | Award | 426 | — | Form 4 |
| Mar 2, 2026 | Penczek Ronald W CAO & Controller | Other | 131 | $39K | Form 4 |
| Mar 2, 2026 | Wessling Erin M EVP & Chief Legal Officer | Award | 2,976 | — | Form 4 |
| Mar 3, 2026 | Wessling Erin M EVP & Chief Legal Officer | Other | 417 | $118K | Form 4 |
| Mar 2, 2026 | Craig Ryan R EVP & Chief HR Officer | Award | 2,976 | — | Form 4 |
| Mar 3, 2026 | Craig Ryan R EVP & Chief HR Officer | Other | 309 | $88K | Form 4 |
Penczek Ronald W
CAO & Controller
Date
May 19
Shares
877
Price
$311.48
Value
$273K
Penczek Ronald W
CAO & Controller
Date
May 19
Shares
654
Price
$271.27
Value
$177K
Penczek Ronald W
CAO & Controller
Date
May 19
Shares
1,531
Price
$403.13
Value
$617K
Kendrick Charles Morgan JR
EVP & President, Commercial
Date
Mar 6
Shares
3,196
Price
$284.92
Value
$911K
Wessling Erin M
EVP & Chief Legal Officer
Date
Mar 3
Shares
417
Price
$284.03
Value
$118K
Craig Ryan R
EVP & Chief HR Officer
Date
Mar 3
Shares
309
Price
$284.03
Value
$88K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About ELV insider trading
ELV insider trades
Elevance Health Inc. (ELV) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Penczek Ronald W (CAO & Controller), BOUDREAUX GAIL (President and CEO · Director), Kendrick Charles Morgan JR (EVP & President, Commercial). Over the past 12 months, 5 insiders have filed transactions with the SEC. ELV insiders have been primarily buying, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Elevance Health Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
ELV insider trading · 5 questionsThe insiders of Elevance Health Inc. (ELV) include executives and directors such as Penczek Ronald W (CAO & Controller), BOUDREAUX GAIL (President and CEO · Director), Kendrick Charles Morgan JR (EVP & President, Commercial), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026